Revenue
$883.4M
▲ 43.8% YoY
Net Income
$78.3M
▲ 522.9% YoY
EPS
$3.32
▲ 419.2% YoY
Cash
$285.6M
▲ 97.1% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sell | Apr 13, 2026 | 500 | $77.95 | $39K | Form 4 ↗ |
Mutz Christopher HEAD OF RARE DISEASE | Sell | Mar 13, 2026 | 3.2K | $71.64 | $227K | Form 4 ↗ |
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sell | Mar 13, 2026 | 500 | $72.62 | $36K | Form 4 ↗ |
Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Sell | Mar 11, 2026 | 4.8K | $74.91 | $357K | Form 4 ↗ |
Mutz Christopher HEAD OF RARE DISEASE | Sell | Mar 9, 2026 | 3.6K | $74.18 | $267K | Form 4 ↗ |
Davis Krista SVP, CHIEF HR OFFICER | Sell | Mar 9, 2026 | 5.1K | $74.13 | $377K | Form 4 ↗ |
Mutz Christopher HEAD OF RARE DISEASE | Sell tax | Mar 7, 2026 | 3.3K | $74.04 | $245K | Form 4 ↗ |
Lalwani Nikhil PRESIDENT & CEO | Sell tax | Mar 7, 2026 | 17.1K | $74.04 | $1.26M | Form 4 ↗ |
Gutwerg Ori SVP, GENERICS | Sell tax | Mar 7, 2026 | 3.3K | $74.04 | $245K | Form 4 ↗ |
CAREY STEPHEN P. SVP & CFO | Sell tax | Mar 7, 2026 | 5.2K | $74.04 | $381K | Form 4 ↗ |
Mutz Christopher HEAD OF RARE DISEASE | Sell | Mar 6, 2026 | 2.1K | $74.22 | $157K | Form 4 ↗ |
Davis Krista SVP, CHIEF HR OFFICER | Sell | Mar 6, 2026 | 1.5K | $75.00 | $111K | Form 4 ↗ |
CAREY STEPHEN P. SVP & CFO | Vest | Mar 5, 2026 | 3.3K | $49.51 | $164K | Form 4 ↗ |
CAREY STEPHEN P. SVP & CFO | Sell | Mar 5, 2026 | 3.3K | $75.42 | $250K | Form 4 ↗ |
CAREY STEPHEN P. SVP & CFO | Sell | Mar 5, 2026 | 4.0K | $75.56 | $302K | Form 4 ↗ |
Gutwerg Ori SVP, GENERICS | Sell | Mar 3, 2026 | 2.1K | $76.50 | $158K | Form 4 ↗ |
Mutz Christopher HEAD OF RARE DISEASE | Sell | Mar 2, 2026 | 417 | $74.00 | $31K | Form 4 ↗ |